HPS1487-95
1139691-72-7
默认>95%HPLC，若需其他规格请洽询
| 产品编号 | 规格 | 货期 | 销售价 | 折扣价 | 数量 | 操作 |
|---|---|---|---|---|---|---|
| HPS1487-95 | 默认>95%HPLC，若需其他规格请洽询 |
25天
|
敬请询价 | 敬请询价 |
 
|
| 名字 | Gastric Inhibitory Polypeptide (6-30) amide (human) trifluoroacetate salt |
|---|---|
| 序列(三字母) | H-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-NH₂ trifluoroacetate salt |
| 序列(单字母) | FISDYSIAMDKIHQQDFVNWLLAQK-NH₂ |
| CAS# | 1139691-72-7 |
| 分子式 | C₁₃₉H₂₀₉N₃₅O₃₈S |
| 分子量 | 3010.47 |
| 纯度 | 默认>95%HPLC，若需其他规格请洽询 |
| 合成方法 | Synthetic |
| 储存条件 | -20 ± 5 °C |
| 应用 | Diabetes |
| 描述 | The porcine homolog of gastric inhibitory polypeptide (6-30) amide (human) also known as glucose-dependent insulinotropic polypeptide (6-30) amide (human) has been found to antagonize the induction of cAMP production of gastric inhibitory polypeptide (human) (GIP (human)) (H-5645) in vitro. In competitive binding studies it has been shown to exhibit receptor binding affinity equivalent to the gastric inhibitory polypeptide (human) (IC₅₀ = 3.08 ± 0.57 nM). |
